Page URL:

Genome-wide study links four new genes to Alzheimer's

3 November 2008
Appeared in BioNews 482

A study examining the genomes of more than 1,300 families has revealed four new genes potentially linked to the most common late-onset form of Alzheimer's disease, according to a study published in the American Journal of Human Genetics last week. The researchers, based at the Massachusetts General Hospital - Mass. General Institute for Neurodegenerative Diseases (MGH-MIND), hope that the findings could provide the starting point for finding new and improved ways of diagnosing and treating the condition.

'Virtually all current research into therapies is based on the Alzheimer's genes that we already know about; so each new gene we find not only enhances our ability to predict and diagnose the disease, but also provides valuable new clues about biochemical events and pathways involved in the disease process,' said Dr Rudolph Tanzi, director of the MGH-MIND Genetics and Aging Research Unit, who co-led the study.

Alzheimer's is a progressive neurodegenerative disorder, characterised by loss of memory and personality changes, which eventually lead to death. Late-onset Alzheimer's is the most common form of the disease, and approximately 700,000 people in the UK are affected by it. In the search for genes linked to late-onset Alzheimer's disease, the researchers scanned the genomes of 400 families, in which at least three family members had developed the condition.

Out of the 500,000 genetic markers analysed, five were associated with Alzheimer's disease. One of the five genes associated was APOE (Apolipoprotein E), a gene identified in previous studies which is thought to play a role in clearing the plaques from the brain, which build up in Alzheimer's patients. To confirm the four remaining sites, the researchers scaled up their study, analysing samples from an additional 900 families. The most strongly associated gene was located on chromosome 14 in the vicinity of a gene called presenilin-1, which is thought to play a role in early-onset Alzheimer's disease.

'The genetic association of Alzheimer's with this novel chromosome 14 gene, which like APOE appears to influence age of onset, is sufficiently strong to warrant intensive follow-up investigations into its role in the process of nerve cell death in this disease,' Tanzi said.

Another of the genes identified is know to cause the neurological condition 'spinocerebellar ataxia', which, like Alzheimer's disease, involves the death of nerve cells at key areas in the central nervous system. The remaining two genes are thought to play a role in the immune system and in maintaining functional synapses, the loss of which is linked to dementia in Alzheimer's disease.

Gene Scan Of Alzheimer's Families Identifies Four New Suspect Genes
ScienceDaily |  30 October 2008
Researchers find more Alzheimer's genes
Reuters |  30 October 2008
Scientists spot 4 new Alzheimer's genes
The Washington Post |  30 October 2008
7 March 2011 - by Alison Cranage 
Scientists at Northwestern University, Chicago have transformed stem cells into a key type of brain cell that dies early in Alzheimer's disease. Their findings will allow scientists to study what causes the cells to die in Alzheimer's, potentially paving the way for new treatments....
18 January 2010 - by Alison Cranage 
American scientists have found that a genetic variation could be associated with slower memory decline and a lower risk of Alzheimer's disease and dementia. The preliminary findings shed light on processes in the brain that could contribute to memory loss and dementia. The work was published in the Journal of the American Medical Association last week....
7 September 2009 - by Ailsa Stevens 
British and French researchers this week announced the discovery of three new genes linked to late-onset Alzheimer's disease, certain variations in which may increase a person's risk of developing the disease by 10-15 per cent. If new drugs could be developed to counter the effects of these mutations, it could help to prevent 20 per cent, the equivalent of 100,000 cases, of Alzheimer's disease in the UK per year, the researchers claim....
19 July 2009 - by Adam Fletcher 
Findings published last week suggest that people are not troubled upon learning they are at higher risk of developing Alzheimer’s disease. Writing in the New England Journal of Medicine, researchers at the Boston University School of Medicine, US, led by Dr Robert Green, measured participants’ anxiety levels following results of a genetic test. The paper arrives amidst debate on how harmful direct-to-customer genetics testing - offered by companies such as 23andMe and DeCodeMe - might actuall...
14 April 2009 - by Ailsa Stevens 
Scientists from the UK's Oxford University and Imperial College London have shown that carriers of a gene variant which increases Alzheimer's risk by up to ten times may have increased brain activity in a key area of the brain, long before symptoms of the disease develop. The...
7 July 2008 - by Alison Cranage 
New research, published last month in the journal Cell, has identified a previously unknown gene, named CALHM1, that is linked with Alzheimer's disease. A certain allele, or version, of this gene, was found to be associated with an increased risk of developing late-onset Alzheimer's. A large international...
28 October 2007 - by Dr Kirsty Horsey 
The largest genome-wide study of the genetic origins of Alzheimer's disease is set to begin, thanks to a £1.3 million grant from the UK's largest charity, the Wellcome Trust. The researchers in the study will look at DNA samples from 6,000 sufferers of late-onset Alzheimer's disease...
24 September 2007 - by Katy Sinclair 
The UK's Human Fertilisation and Embryology Authority (HFEA) has given permission to a fertility clinic to test a couple's embryos for early-onset Alzheimer's disease, a genetic condition that can manifest from the age of 35. The Bridge Centre has been granted the licence to screen embryos for...
17 April 2007 - by Dr Alan Thornhill 
We are currently planning to help the first British couple have a baby free from the risk of developing early-onset Alzheimer's disease (EOAD). Preimplantation genetic diagnosis (PGD) for this disease, which affects individuals in middle age (40s and 50s) - rather than the more common Alzheimer's whose effects are suffered considerably...
4 April 2007 - by Dr Jess Buxton 
According to the Sunday Times newspaper, a UK clinic is requesting permission to test embryos in order to select those free from early onset Alzheimer's disease. Charl and Danielle de Beer are planning undergo IVF treatment in conjunction with preimplantation genetic diagnosis (PGD) at the Bridge...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.